🇺🇸 FDA
Patent

US 10398662

GHB formulation and method for its manufacture

granted A61KA61K31/19A61K31/785

Quick answer

US patent 10398662 (GHB formulation and method for its manufacture) held by JAZZ PHARMA IRELAND LIMITED expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
JAZZ PHARMA IRELAND LIMITED
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/19, A61K31/785, A61K38/02, A61K9/10